Emil Hartela Investing

Emil Hartela Investing

Home
Archive
Leaderboard
About
$HAYPP Watch: August 2025
Signal over noise; slight August pullback; baseline strength persists
17 hrs ago • 
Emil
2
ZYN is back; Haypp’s U.S. engine restarts
$HAYPP update
Sep 5 • 
Emil
2
Haypp Group: Deep Dive
The Best Winner of the Nicotine Pouch Boom $HAYPP
Sep 2 • 
Emil
6
2
The Tempus AI Pitch: Why It’s the ChatGPT of Healthcare
Turning billions of medical datapoints into diagnostics, drug discovery, and investor upside. $TEM
Aug 29 • 
Emil
1
Recursion Pharmaceuticals: The $100 Trillion Pitch ($RXRX)
Unlocking the next wave of human health and economic growth.
Aug 28 • 
Emil
The Pitch: Turning Point Brands’ Bet Against ZYN’s Monopoly
It isn’t hard to see a path where TPB becomes a $5B company
Aug 24 • 
Emil
Execution Memo No. 001
When Data Shifts; Positions; Plans; Perspective; 2025.08.23
Aug 23 • 
Emil
3
$HAYPP Watch: July 2025
We have liftoff: momentum builds into Q3
Aug 19 • 
Emil
3
Emil Hartela Investing
Emil Hartela Investing
Notes from an investor who never bought into the Efficient Market Hypothesis

Emil Hartela Investing

AboutArchiveSitemap
© 2025 Emil
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture